Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Free racing games - play racing games on flashracingonline.
Popular Articles

FDA Approves Feraheme™ To Treat Iron Deficiency Anemia In Adult Chronic Kidney Disease Patients
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Feraheme™ (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease. The recommended dose of Feraheme is an initial 510 mg IV injection followed by a second 510 mg IV injection three to eight days later. Feraheme should be administered as an undiluted IV injection delivered at a rate of up to 1 mL/sec (30 mg/sec). The recommended Feraheme dose may be readministered to patients with persistent or recurrent iron deficiency anemia.

New Online Scheme To Help Families Caring For Sick And Disabled Children, Wales
Help for families with sick and disabled children in Wales is now available at the click of a mouse, Deputy Minister for Social Services Gwenda Thomas will announce.
News of the day
Test Detects Molecular Marker Of Aging In Humans
In 2004, researchers at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center announced a crucial discovery in the understanding of cellular aging. They found that as cells and tissues age, the expression of a key protein, called p16INK4a, dramatically increases in most mammalian organs. Because p16INK4a is a tumor suppressor protein, cancer researchers are interested in its role in cellular aging and cancer prevention.
Medical Devices

UNAIDS Director Calls For G8 To Come Through On HIV/AIDS Funding Pledges

Michel Sidibe, the executive director of UNAIDS, voiced concerns that wealthy nations who previously pledged to help Africa stop the spread of HIV/AIDS during the G8 summit four years ago, might instead use funds to bolster their own ailing economies, Reuters reports. "Before this financial crisis, the world came together and this solidarity helped put more than 3.5 million people on treatment," Sidibe told reporters during the African Union summit in Sirte, Libya. "I am very concerned because ... the leaders of this world have the political obligation, or responsibility to really fix the market but they have also the moral obligation to not abandon those ... people on treatment and not to break the hope of the 14 million (AIDS) orphans," he said. Reuters writes: "At the G8 summit in the Scottish town of Gleneagles in 2005, the world"s wealthiest industrialised democracies promised to provide universal access to anti-HIV drugs in Africa by 2010 - an undertaking costing billions of dollars," yet "[e]ven before the global downturn, non-governmental groups that campaign on AIDS said the G8 states were not providing adequate funding to meet their target." As an example of funding shortcomings for international HIV/AIDS programs, Sidibe pointed out that Global Fund to Fight AIDS, Tuberculosis and Malaria is about "$4 billion short of the amount it needed to fund AIDS projects it was already running or had committed to financing," according to Reuters (Lowe, 7/1). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009